Literature DB >> 15056831

Sleep-disordered breathing in patients with idiopathic cardiomyopathy.

Katsuhisa Banno1, Toshiaki Shiomi, Ryujiro Sasanabe, Kazuo Otake, Rika Hasegawa, Masato Maekawa, Takayuki Ito.   

Abstract

BACKGROUND: Sleep-disordered breathing may adversely affect heart function, and thereby contribute to the progression of heart failure. A study was undertaken in patients with idiopathic cardiomyopathy to document the characteristics of sleep-disordered breathing. METHODS AND
RESULTS: Thirty-five patients with a diagnosis of idiopathic cardiomyopathy, comprising 20 patients with dilated cardiomyopathy (DCM) and 15 patients with hypertrophic cardiomyopathy (HCM), underwent overnight polysomnography. Of these 35, 16 (80%) of the DCM patients and 7 (47%) of the HCM patients had sleep-disordered breathing. Central sleep apnea-hypopnea syndrome (CSAHS) was seen in 10 DCM patients, but not in the HCM patients, and obstructive sleep apnea-hypopnea syndrome (OSAHS) was seen in 6 DCM patients and 7 HCM patients. CSAHS was seen in DCM patients with a low left ventricular ejection fraction. HCM patients with OSAHS had a significantly greater body mass index (BMI) than those without OSAHS and CSAHS (27.6 +/- 3.8 vs 22.0 +/- 4.0 kg/m2, p<0.05). DCM patients with OSAHS had a larger BMI than those with CSAHS (29.3 +/- 5.8 vs 24.2 +/- 4.0 kg/m2, p<0.05) and those without OSAHS and CSAHS (29.3 +/- 5.8 vs 21.3 +/- 3.1 kg/m2, p<0.05).
CONCLUSIONS: Sleep-disordered breathing is common in patients with idiopathic cardiomyopathy; half of DCM patients had CSAHS, which was closely associated with obesity.

Entities:  

Mesh:

Year:  2004        PMID: 15056831     DOI: 10.1253/circj.68.338

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

1.  Hypertrophic obstructive cardiomyopathy and sleep-disordered breathing: an unfavorable combination.

Authors:  Partho P Sengupta; Dan Sorajja; Mackram F Eleid; Virend K Somers; Steve R Ommen; James M Parish; Bijoy Khandheria; A Jamil Tajik
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-18

Review 2.  Sleep disordered breathing and its treatment in congestive heart failure.

Authors:  L J Cormican; A Williams
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

3.  Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac Amyloidosis.

Authors:  Diane Bodez; Aziz Guellich; Mounira Kharoubi; Ala Covali-Noroc; Claire-Marie Tissot; Soulef Guendouz; Luc Hittinger; Jean-Luc Dubois-Randé; Jean-Pascal Lefaucheur; Violaine Planté-Bordeneuve; Serge Adnot; Laurent Boyer; Thibaud Damy
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

4.  Risk of glomerular filtration rate decline in patients with hypertrophic cardiomyopathy and obstructive sleep apnoea.

Authors:  Shao-Yun Wang; Jing Luo; Yi-Fei Dong; Xu-Yang Liu; Ying-Li Fan; Ming Deng; Da-Wei Chen; Ping Li; Xiao-Shu Cheng
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

5.  Diffuse Alveolar Hemorrhage Associated with Dilated Cardiomyopathy and Sleep Apnea Syndrome.

Authors:  Ryohei Suematsu; Jun Miyata; Tomoya Sano; Chie Watanabe; Yohei Maki; Yoshifumi Kimizuka; Nobuyoshi Hayashi; Yuji Fujikura; Hiroaki Sugiura; Hiroshi Shinmoto; Akira Taruoka; Yuji Nagatomo; Takeshi Adachi; Akihiko Kawana
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

6.  Sleep-disordered breathing in heart failure patients with different etiologies.

Authors:  Tao Wang; Fu-Chao Yu; Qin Wei; Xuan Xu; Liang Xie; Ning Ding; Jia-Yi Tong
Journal:  Clin Cardiol       Date:  2022-05-10       Impact factor: 3.287

7.  Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy.

Authors:  Flávia B Nerbass; Rodrigo P Pedrosa; Pedro R Genta; Murillo O Antunes; Edmundo Arteaga-Fernández; Luciano F Drager; Geraldo Lorenzi-Filho
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

Review 8.  Sleep Disordered Breathing in Hypertrophic Cardiomyopathy-Current State and Future Directions.

Authors:  Shreyas Venkataraman; Shahid Karim; Aiswarya Rajendran; C Anwar A Chahal; Virend K Somers
Journal:  J Clin Med       Date:  2020-03-25       Impact factor: 4.241

9.  Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

Authors:  Haobo Xu; Juan Wang; Jiansong Yuan; Fenghuan Hu; Weixian Yang; Chao Guo; Xiaoliang Luo; Rong Liu; Jingang Cui; Xiaojin Gao; Yushi Chun; Shubin Qiao
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

10.  Obstructive Sleep Apnea Impacts Cardiac Function in Dilated Cardiomyopathy Patients Through Circulating Exosomes.

Authors:  Hui Gong; Xing Lyu; Lini Dong; Shengyu Tan; Shizhen Li; Jieting Peng; Yang Liu; Xiangyu Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.